Riskpilot← Back to searchSign inGet full accessMedmax Oy
OYActiveY-tunnus 0929717-0Puutarhatie 6Logistics service activities · NACE 5225Est. 1993— employees
Revenue 2025
EUR 40K
+27% vs 2024
EBITDA margin
8.8%
-39% vs 2024
Equity ratio
97.3%
Financial strength
Net profit 2025
EUR 3K
+33% vs 2024
| Revenue | EUR 40K | +27% |
| EBITDA | EUR 4K | -39% |
| Net profit | EUR 3K | +33% |
| Total assets | EUR 26K | +10% |
| Equity | EUR 25K | +12% |
| Employees | — | — |
Legal name
Medmax Oy
Y-tunnus number
0929717-0
Legal form
Osakeyhtiö
NACE code
5225 · Logistics service activities
Founded
28. huhtikuuta 1993
Share capital
EUR 2 523
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on huolinta ja rahtaus.
Address
Puutarhatie 6
Phone
+3580500778390
Email
aki.fager@kolumbus.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 20 | 12 | 23 | 32 | 40 |
| Staff expenses | −4 | −5 | −5 | −22 | −32 |
| EBITDA | 1 | −1 | 14 | 6 | 4 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −1 | 13 | 6 | 3 |
| Net financials | 0 | 0 | 0 | −0 | 0 |
| Profit before tax | 0 | −1 | 13 | 6 | 3 |
| Tax | −0 | −0 | −0 | 4 | 1 |
| Net profit | 0 | −1 | 13 | 2 | 3 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 | 7 | 20 | 23 | 26 |
| Equity | 8 | 7 | 20 | 22 | 25 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 1 | 1 |
| Total debt | 0 | 0 | 0 | 1 | 1 |
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
20212025
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20212025
Return on equity
11.0%
This company
18.4%
Market median
+40% vs market
20212025
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20212025
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TM Audit | Audit | 2021 |
AO Chief Executive Officer | Chief Executive Officer | 2021 |
PJ Deputy auditor | Deputy auditor | 2021 |
TT Deputy Member | Deputy Member | 2021 |
| Former (3) | ||
TH Audit | Audit | 2002 – 2021 |
AJ Chief Executive Officer | Chief Executive Officer | 2002 – 2021 |
AA Deputy auditor | Deputy auditor | 2002 – 2021 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medmax Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Matti Kervinen | Audit | 0 companies |
| Aki Ossian Fager | Chief Executive Officer | 0 companies |
| Teija Helena Moisala | Audit | 0 companies |
| Altti Juhani Fager | Chief Executive Officer | 0 companies |
| Perttu Johannes Mettomäki | Deputy auditor | 0 companies |
| Ari Aartola | Deputy auditor | 0 companies |
| Teija Tuulikki Reunanen | Deputy Member | 0 companies |